Silvio Borges dos Santos Fachim assume a liderança do Departamento Jurídico da farmacêutica, trazendo quase 20 anos de ...

Em abril, o CEO do Grupo SBF será Gustavo Furtado, vindo da Centauro e que sucede Pedro Zemel. Gustavo Furtado. Foto: ...

Pela primeira vez, a Biogen Brasil, empresa líder global em biotecnologia, é certificada pelo Great Place To Work®. O prêmio é baseado no que os funcionários dizem a respeito de sua experiência de ...

The drug is also approved in the U.S. and is under review in Canada, Brazil, South Korea and other ... The high-dose Spinraza is Biogen's answer to competitors such as Novartis' gene therapy ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neuroscience and neurodegenerative diseases with a market capitalization of $20.1 billion, finds itself at a critical ...

Biogen's Q4 2024 earnings showed slight revenue growth but Wall Street remains unimpressed due to weak guidance and declining key drug franchises. Leqembi's commercial performance is disappointing ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neuroscience and neurodegenerative diseases with a market capitalization of $20.1 billion, finds itself at a critical ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

Biogen Pharmachem Industries Ltd share price was up by 3.96% from the previous closing price of ₹1.01. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...